Skip to main content

References for The Edge Winter 2023 Issue

  1. Hedegaard H, Bastian BA, Trinidad JP, Spencer M, Warner M. Drugs Most Frequently Involved in Drug Overdose Deaths: United States, 2011-2016. Natl Vital Stat Rep. 2018;67(9):1-14.
  2. Schifano F, Chiappini S, Miuli A, et al. Focus on over-the-counter drugs' misuse: A systematic review on antihistamines, cough medicines, and decongestants. Frontiers in Psychiatry. 2021;12. doi:10.3389/fpsyt.2021.657397
  3. Morris S. 21 Disasterous TikTok trends every parent should be aware of. Newsweek. https://www.newsweek.com/21-dangerous-tiktok-trends-that-have-gone-viral-1573734. Published March 6, 2021. Accessed May 5, 2023
  4. Cutler A. TikTok swears by ‘Blackout Rage Gallons’ called borgs. But college trend worries some . Miami Herald. February 15, 2023.
  5. Alvarez D. Benadryl (diphenhydramine): Indications, side effects, interactions, and overdose. Benadryl (Diphenhydramine): Indications, Side effects, Interactions, and Overdose | Poison Control. https://www.poison.org/articles/benadryl-diphenhydramine. Published 2023. Accessed May 5, 2023.
  6. CP; SVZ. Diphenhydramine. National Center for Biotechnology Information. https://pubmed.ncbi.nlm.nih.gov/30252266/. Published July 11, 2022. Accessed April 26, 2023.
  7. Simons KJ, Watson WT, Martin TJ, Chen MX, Simons FE. Diphenhydramine: Pharmacokinetics and pharmacodynamics in elderly adults, young adults, and children. The Journal of Clinical Pharmacology. 1990;30(7):665-671. doi:10.1002/j.1552-4604.1990.tb01871.x
  8. Diphenhydramine dosing table. HealthyChildren.org. Accessed May 5, 2023.
  9. B; BEDMHC. Anticholinergic toxicity. National Center for Biotechnology Information. https://pubmed.ncbi.nlm.nih.gov/30521219/. Published March 2023. Accessed April 26, 2023.
  10. Cole JB, Stellpflug SJ, Gross EA, Smith SW. Wide complex tachycardia in a pediatric diphenhydramine overdose treated with sodium bicarbonate. Pediatr Emerg Care. 2011;27(12):1175-1177. doi:10.1097/PEC.0b013e31823b0e47
  11. Nishino T, Wakai S, Aoki H, Inokuchi S. Cardiac arrest caused by diphenhydramine overdose. Acute Medicine & Surgery. 2018;5(4):380-383. doi:10.1002/ams2.351
  12. Sanello A, Gausche-Hill M, Mulkerin W, et al. Altered Mental Status: Current Evidence-based Recommendations for Prehospital Care. West J Emerg Med. 2018;19(3):527-541. doi:10.5811/westjem.2018.1.36559
  13. Kelly CA, Upex A, Bateman DN. Comparison of consciousness level assessment in the poisoned patient using the alert/verbal/painful/unresponsive scale and the Glasgow Coma Scale. Ann Emerg Med. 2004;44(2):108-113. doi:10.1016/j.annemergmed.2004.03.028
  14. Approach to altered mental status. https://www.saem.org/about-saem/academies-interest-groups-affiliates2/cdem/for-students/online-education/m4-curriculum/group-m4-approach-to/approach-to-altered-mental-status. Published September 2019. Accessed April 26, 2023.
  15. Rosenbaum TG, Kou M. Are one or two dangerous? Tricyclic antidepressant exposure in toddlers. J Emerg Med. 2005;28(2):169-174. doi:10.1016/j.jemermed.2004.08.018
  16. Woolf AD, Erdman AR, Nelson LS, et al. Tricyclic antidepressant poisoning: an evidence-based consensus guideline for out-of-hospital management. Clin Toxicol (Phila). 2007;45(3):203-233. doi:10.1080/15563650701226192
  17. Nguyen TT, Armengol C, Wilhoite G, Cumpston KL, Wills BK. Adverse events from physostigmine: An observational study. Am J Emerg Med. 2018;36(1):141-142. doi:10.1016/j.ajem.2017.07.006
  18. Boley SP, Olives TD, Bangh SA, Fahrner S, Cole JB. Physostigmine is superior to non-antidote therapy in the management of antimuscarinic delirium: a prospective study from a regional poison center. Clin Toxicol (Phila). 2019;57(1):50-55. doi:10.1080/15563650.2018.1485154
  19. Suchard JR. Assessing physostigmine's contraindication in cyclic antidepressant ingestions. J Emerg Med. 2003;25(2):185-191. doi:10.1016/s0736-4679(03)00169-0
  20. Arens AM, Shah K, Al-Abri S, Olson KR, Kearney T. Safety and effectiveness of physostigmine: a 10-year retrospective review. Clin Toxicol (Phila). 2018;56(2):101-107. doi:10.1080/15563650.2017.1342828
  21. Wang GS, Baker K, Ng P, et al. A randomized trial comparing physostigmine vs Lorazepam for treatment of antimuscarinic (anticholinergic) toxidrome. Clinical Toxicology. 2020;59(8):698-704. doi:10.1080/15563650.2020.1854281
  22. Burns MJ, Linden CH, Graudins A, Brown RM, Fletcher KE. A comparison of physostigmine and benzodiazepines for the treatment of anticholinergic poisoning. Ann Emerg Med. 2000;35(4):374-381. doi:10.1016/S0196-0644(00)70057-6
  23. Andrade OA, Zafar Gondal A. Physostigmine. [Updated 2022 May 26]. In: StatPearls. Treasure Island (FL).
  24. Bier SA, Borys DJ. Emergency medical services' use of Poison Control Centers for Unintentional Drug Ingestions. The American Journal of Emergency Medicine. 2010;28(8):911-914. doi:10.1016/j.ajem.2009.05.015
  25. Levine M, Flores J, Seabury SA, Sanko S, Eckstein M. Impact of the use of regional poison control centers in an urban Ems Dispatch System. Journal of Medical Toxicology. 2016;13(1):47-51. doi:10.1007/s13181-016-0586-0
  26. Lovejoy FH, Robertson WO, Woolf AD. Poison Centers, Poison Prevention, and the pediatrician. Pediatrics. 1994;94(2):220-224. doi:10.1542/peds.94.2.220
  27. Rosen S. Emergency medical services. Connecticut Poison Control Center. https://health.uconn.edu/poison-control/health-care-providers/emergency-medical-services/. Published December 29, 2016. Accessed May 7, 2023.
  28. Vilke GM, Bozeman WP, Dawes DM, DeMers G, Wilson MP. Excited delirium syndrome (ExDS): Treatment options and considerations. Journal of Forensic and Legal Medicine. 2012;19(3):117-121. doi:10.1016/j.jflm.2011.12.009

 

  1. Sandoval S, Goyal A, Frawley J, et al. Prehospital use of ketamine versus benzodiazepines for sedation among pediatric patients with behavioral emergencies. Prehospital Emergency Care. Published online 2023:1-7. doi:10.1080/10903127.2022.2163326

 

  1. Brown LH, Crowe RP, Pepe PE, et al. Adverse events following emergent prehospital sedation of patients with behavioral emergencies: A retrospective cohort study. The Lancet Regional Health - Americas. 2022;9:100183. doi:10.1016/j.lana.2021.100183

 

  1. Linder LM, Ross CA, Weant KA. Ketamine for the acute management of excited delirium and agitation in the prehospital setting. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. 2017;38(1):139-151. doi:10.1002/phar.2060

 

  1. Gee SW, Lin A, Tobias JD. Dexmedetomidine Infusion to Control Agitation due to Anticholinergic Toxidromes in Adolescents, a Case Series. J Pediatr Pharmacol Ther. 2015;20(4):329-334.

 

  1. Jang DH, Manini AF, Trueger NS, et al. Status epilepticus and wide-complex tachycardia secondary to diphenhydramine overdose. Clin Toxicol (Phila). 2010;48(9):945-948.

 

  1. Thomas SH, Behr ER. Pharmacological treatment of acquired QT prolongation and torsades de pointes. Br J Clin Pharmacol. 2016;81(3):420-427.

 

  1. El-Sherif N, Turitto G, Boutjdir M. Acquired Long QT Syndrome and Electrophysiology of Torsade de Pointes. Arrhythm Electrophysiol Rev. 2019;8(2):122-130.

 

  1. Schneck HJ, Rupreht J. Central anticholinergic syndrome (CAS) in anesthesia and intensive care. Acta Anaesthesiol Belg. 1989;40(3):219-228.

 

  1. Torline RL. Extreme hyperpyrexia associated with central anticholinergic syndrome. Anesthesiology. 1992;76(3):470-471.

 

  1. Hoffmann K. Cooling by convection vs cooling by conduction for treatment of fever in critically ill adults. American Journal of Critical Care. 2001;10(4):294-295. doi:10.4037/ajcc2001.10.4.294

 

  1. Cho YS, Lim H, Kim SH. Comparison of lactated Ringer's solution and 0.9% saline in the treatment of rhabdomyolysis induced by doxylamine intoxication. Emerg Med J. 2007;24(4):276-280.

 

  1. Ali Z, Khan M, Ullah W, Kpehor AA, Cheema MA. QT interval prolongation and rhabdomyolysis associated with diphenhydramine toxicity: a case report. J Community Hosp Intern Med Perspect. 2020;10(2):151-153

 

  1. Long B, Koyfman A, Gottlieb M. An evidence-based narrative review of the emergency department evaluation and management of rhabdomyolysis. Am J Emerg Med. 2019;37(3):518-523.

 

  1. Cervellin G, Comelli I, Benatti M, Sanchis-Gomar F, Bassi A, Lippi G. Non-traumatic rhabdomyolysis: Background, laboratory features, and acute clinical management. Clin Biochem. 2017;50(12):656-662.